Cargando…

Parkinson's disease prevalence in Fabry disease: A survey study

Recent research has suggested a possible link between Parkinson's disease (PD) and Fabry disease. To test this relationship, we administered a self-report and family history questionnaire to determine the prevalence of PD in Fabry disease patients and family members with likely pathogenic alpha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wise, Adina H., Yang, Amy, Naik, Hetanshi, Stauffer, Chanan, Zeid, Natasha, Liong, Christopher, Balwani, Manisha, Desnick, Robert J., Alcalay, Roy N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683804/ https://www.ncbi.nlm.nih.gov/pubmed/29159076 http://dx.doi.org/10.1016/j.ymgmr.2017.10.013

Ejemplares similares

The N370S/R496H genotype in type 1 Gaucher disease – Natural history and implications for pre symptomatic diagnosis and counseling
por: Zeid, Natasha, et al.
Publicado: (2020)

Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York
por: Fierro, Luca, et al.
Publicado: (2021)

Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York
por: Fierro, Luca, et al.
Publicado: (2021)

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease
por: Galper, Jasmin, et al.
Publicado: (2021)

Prevalence of Fabry Disease among Patients with Parkinson's Disease
por: Lackova, Alexandra, et al.
Publicado: (2022)

eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials
por: Manjrekar, Kriti, et al.
Publicado: (2022)

A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
por: Balwani, Manisha, et al.
Publicado: (2022)

A 51-Year-Old Woman With Interstitial Lung Disease and Subsequent COVID-19 Presenting With Worsening Dyspnea
por: Ng, Nicole, et al.
Publicado: (2022)

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
por: Surface, Matthew, et al.
Publicado: (2021)

Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X‐linked protoporphyria
por: Naik, Hetanshi, et al.
Publicado: (2019)

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
por: Schneider, Susanne A., et al.
Publicado: (2020)

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
por: Schiffmann, Raphael, et al.
Publicado: (2009)

Prevalence of symptoms in female Fabry disease patients: a case-control survey
por: Bouwman, Machtelt G., et al.
Publicado: (2012)

Prevalence of papillary muscle hypertrophy in fabry disease
por: Cianciulli, Tomás Francisco, et al.
Publicado: (2023)

Evaluating the Patient Reported Outcomes Measurement Information System Scales in Acute Intermittent Porphyria
por: Naik, Hetanshi, et al.
Publicado: (2019)

Parkinson’s Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees
por: Gago, Miguel Fernandes, et al.
Publicado: (2020)

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
por: Zedde, Marialuisa, et al.
Publicado: (2022)

Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study
por: Jahan, Sadia, et al.
Publicado: (2020)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study
por: Xu, Yaqian, et al.
Publicado: (2022)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Prevalence of Fabry disease-causing variants in the UK Biobank
por: Gilchrist, Mark, et al.
Publicado: (2023)

Fabry disease: Identification of 50 novel α-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations
por: Shabbeer, Junaid, et al.
Publicado: (2006)

Fabry disease: a survey of visual and ocular symptoms
por: Davey, Pinakin Gunvant
Publicado: (2014)

A survey on the patient journey in Fabry disease in Japan
por: Tsurumi, Mina, et al.
Publicado: (2022)

Prevalence of cerebral small vessel disease in a Fabry disease cohort
por: Tapia, Daisy, et al.
Publicado: (2021)

Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease
por: Marshall, John, et al.
Publicado: (2010)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study
por: Feeney, Megan P., et al.
Publicado: (2021)

Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy
por: Kim, Woo-Shik, et al.
Publicado: (2019)

The Prevalence of Fabry Disease Among Young Cryptogenic Stroke Patients
por: Alhazzaa, Mohammed A, et al.
Publicado: (2020)

Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy
por: Heo, Sun Hee, et al.
Publicado: (2017)

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
por: Beck, Michael, et al.
Publicado: (2015)

Gender Differences in the Application of Spanish Criteria for Initiation of Enzyme Replacement Therapy for Fabry Disease in the Fabry Outcome Survey
por: Barba-Romero, Miguel-Ángel, et al.
Publicado: (2016)

Survey about the Quality of Life of Italian Patients with Fabry Disease
por: Polistena, Barbara, et al.
Publicado: (2021)

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
por: Germain, Dominique P, et al.
Publicado: (2015)

SCARB2 variants and glucocerebrosidase activity in Parkinson’s disease
por: Alcalay, Roy N, et al.
Publicado: (2016)

Atherosclerosis in Fabry Disease—A Contemporary Review
por: Roy, Ashwin, et al.
Publicado: (2021)

Prevalence of Fabry disease in male dialysis patients: Argentinean screening study
por: Frabasil, Joaquín, et al.
Publicado: (2019)

Prevalence of Fabry Disease in Patients With Cryptogenic Strokes: A Systematic Review
por: Ortiz, Juan Fernando, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9v46b4liv2los2koc6od3fehao